Connecting you to content on EBSCOhost

Works matching IS 10109609 AND DT 2003 AND VI 17 AND IP 4

Results: 35

1

Supplying quality medicines for filariasis elimination.

Published in:: 2003
Publication type:: Journal Article

2

International Nonproprietary Names for Pharmaceutical Substances (INN).

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 267
Publication type:: Article

3

Chagas disease.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 265
Publication type:: Article

4

Neglected Diseases.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 265
Publication type:: Article

5

Action against counterfeit medicines in Asia and Africa.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 263
Publication type:: Article

6

Direct-to-consumer advertising and patients.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 262
Publication type:: Article

7

New advice on hormone replacement therapy.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 260
Publication type:: Article

8

WHO review of NICE in the United Kingdom.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 257
Publication type:: Article

9

Placebo or active control? Either, as long as it is in the patient's interest.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 253
Publication type:: Article

10

Virologic non-response in more HIV combinations.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 252
Publication type:: Article

11

Memantine approved for Alzheimer disease.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 251
Publication type:: Article

12

Nimesulide-containing products reevaluated.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 251
Publication type:: Article

13

Recombinant antihaemophilic factor: dose monitoring required.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 251
Publication type:: Article

14

Bicalutamide: do not use in localized prostate cancer.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 250
Publication type:: Article

15

Coronary Stents and thrombosis.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 250
Publication type:: Article

16

Tetrahydrogestrinone: grave risks to health.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 250
Publication type:: Article

17

Daptomycin: new class of antibiotic approved.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 249
Publication type:: Article

18

Levomethadyl discontinued.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 249
Publication type:: Article

19

Nefazodone discontinued.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 248
Publication type:: Article

20

Daclizumab: safety alert.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 248
Publication type:: Article

21

Recommended influenza vaccine for 2004 (Southern hemisphere).

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 248
Publication type:: Article

22

Supplying quality medicines for filariasis elimination.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 244
Publication type:: Article

23

Anti-epileptic drugs, pregnancy and fetal malformations.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 242
Publication type:: Article

24

Convulsions and blood dyscrasias with mirtazapine.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 241
Publication type:: Article

25

Rofecoxib, celecoxib and cardiovascular risk.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 241
Publication type:: Article

26

Atazanavir and tenofovir combination cautioned.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 240
Publication type:: Article

27

Blue discoloration and death from FD&C Blue No. 1.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 239
Publication type:: Article

28

Treatment study for West Nile virus.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 238
Publication type:: Article

29

Adhesion prevention solutions in gynecological procedures.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 238
Publication type:: Article

30

Fluticasone and adrenal suppression.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 237
Publication type:: Article

31

Bisphosphonates and ocular disorders.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 236
Publication type:: Article

32

Serious gastrointestinal effects with celecoxib and rofecoxib.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 235
Publication type:: Article

33

ACE inhibitor, diuretic and NSAID: a dangerous combination.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 235
Publication type:: Article

34

Maternal use of SSRIs and neonatal effects.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 234
Publication type:: Article

35

Medical device regulation: a model framework.

Published in:: WHO Drug Information, 2003, v. 17, n. 4, p. 231
Publication type:: Article